Programme
AASLD-HKASLD Joint Symposium (2): Advanced Liver Disease
Management of Patients in The Baveno VII Gray Zone
Role of Gut Microbiota in Advanced Liver Disease
Use of Vasoactive Drugs and Albumin in Cirrhosis
Frontiers in GI Endoscopy (FGIE) Symposium – Advances in interventional EUS
Room N102 & 3
09:00-10:30
Tips and Tricks for EUS-Guided Gastroenterostomy
EUS-Guided Hepaticogastrostomy and Hepaticoduodenostomy for Malignant Hilar Obstruction
Troubleshooting in EUS-Guided Biliary Access and Drainage
How to Optimize Results for EUS-Guided Liver Biopsy
State Key Lab Meeting (3): Microbiome and Cancer
Room N111 & 12
09:00-10:30
Gut microbiota: Recent updates in Gut
General Overview of Gut Microbiota in Health and Disease
Gut Microbiome in GI Cancer
General Hepatology Update
HCC Risk Prediction – Is There Room for Improvement?
Micro-elimination of HCV in Hong Kong
State Key Lab Meeting (4): GI Cancer Biology
Room N111 & 12
11:00-12:30
Role of Microbiome in Metabolic Associated Cancers
** Programme last updated in April 2024